MMP9 and Guillain-Barre syndrome: Demestre et al. (2005) indicated that serum pro-form of MMP-9 concentrations were significantly higher in ALS patients than in healthy controls and significantly higher in sera from Guillain–Barre syndrome (GBS) patients compared with either ALS patients or healthy controls.